rs3762171
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_015386.3(COG4):c.646C>T(p.Leu216Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.432 in 1,613,736 control chromosomes in the GnomAD database, including 154,948 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 12317 hom., cov: 32)
Exomes 𝑓: 0.44 ( 142631 hom. )
Consequence
COG4
NM_015386.3 synonymous
NM_015386.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.38
Genes affected
COG4 (HGNC:18620): (component of oligomeric golgi complex 4) The protein encoded by this gene is a component of an oligomeric protein complex involved in the structure and function of the Golgi apparatus. Defects in this gene may be a cause of congenital disorder of glycosylation type IIj. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 16-70512331-G-A is Benign according to our data. Variant chr16-70512331-G-A is described in ClinVar as [Benign]. Clinvar id is 95699.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-70512331-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=3.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.63 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG4 | NM_015386.3 | c.646C>T | p.Leu216Leu | synonymous_variant | 5/19 | ENST00000323786.10 | NP_056201.2 | |
COG4 | NM_001195139.2 | c.634C>T | p.Leu212Leu | synonymous_variant | 5/18 | NP_001182068.2 | ||
COG4 | NM_001365426.1 | c.220C>T | p.Leu74Leu | synonymous_variant | 6/20 | NP_001352355.1 | ||
COG4 | NR_158212.1 | n.657C>T | non_coding_transcript_exon_variant | 5/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG4 | ENST00000323786.10 | c.646C>T | p.Leu216Leu | synonymous_variant | 5/19 | 1 | NM_015386.3 | ENSP00000315775.5 |
Frequencies
GnomAD3 genomes AF: 0.394 AC: 59812AN: 151834Hom.: 12310 Cov.: 32
GnomAD3 genomes
AF:
AC:
59812
AN:
151834
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.453 AC: 113729AN: 250938Hom.: 27083 AF XY: 0.464 AC XY: 62994AN XY: 135650
GnomAD3 exomes
AF:
AC:
113729
AN:
250938
Hom.:
AF XY:
AC XY:
62994
AN XY:
135650
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.436 AC: 637618AN: 1461784Hom.: 142631 Cov.: 49 AF XY: 0.443 AC XY: 321904AN XY: 727206
GnomAD4 exome
AF:
AC:
637618
AN:
1461784
Hom.:
Cov.:
49
AF XY:
AC XY:
321904
AN XY:
727206
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.394 AC: 59847AN: 151952Hom.: 12317 Cov.: 32 AF XY: 0.398 AC XY: 29583AN XY: 74260
GnomAD4 genome
AF:
AC:
59847
AN:
151952
Hom.:
Cov.:
32
AF XY:
AC XY:
29583
AN XY:
74260
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2166
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 11, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
COG4-congenital disorder of glycosylation Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Microcephalic osteodysplastic dysplasia, Saul-Wilson type Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at